SD-3212 is a new antiarrhythmic agent that functions as a use- and voltage-dependent inactivated sodium channel blocker with kinetics between fast and intermediate Class-I drugs.
No takes yet. Share an insight, caveat, or question.
SD-3212's profile supports preclinical antiarrhythmic development; leaves open efficacy, safety, and human translation.
Kodama et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: